Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + carboplatin versus MVP or MIC for advanced inoperable non-small cell lung cancer
ISRCTN41486350Phase 3Completed
- Sponsor
- United States Department of Health and Human Services
- Start
- Apr 1998
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3 trial of gemcitabine, carboplatin, mitomycin c, vinblastine, cisplatin and 1 more, sponsored by United States Department of Health and Human Services. Started Apr 1998; status: completed.
02
Drugs
gemcitabinecarboplatinmitomycin cvinblastinecisplatin
Beyond the preview
Go deeper on ISRCTN41486350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN41486350.